- Home
- SBFM vs LTH Comparison
SBFM vs LTH Comparison
Compare SBFM & LTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- LTH
- Stock Information
- Founded
- SBFM 2006
- LTH 1992
- Country
- SBFM United States
- LTH United States
- Employees
- SBFM N/A
- LTH N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- LTH Hotels/Resorts
- Sector
- SBFM Health Care
- LTH Consumer Discretionary
- Exchange
- SBFM Nasdaq
- LTH Nasdaq
- Market Cap
- SBFM 4.9M
- LTH N/A
- IPO Year
- SBFM N/A
- LTH 2021
- Fundamental
- Price
- SBFM $1.44
- LTH $31.23
- Analyst Decision
- SBFM Strong Buy
- LTH Buy
- Analyst Count
- SBFM 1
- LTH 12
- Target Price
- SBFM $15.00
- LTH $33.21
- AVG Volume (30 Days)
- SBFM 4.4M
- LTH 2.2M
- Earning Date
- SBFM 05-19-2025
- LTH 05-08-2025
- Dividend Yield
- SBFM N/A
- LTH N/A
- EPS Growth
- SBFM N/A
- LTH 100.00
- EPS
- SBFM N/A
- LTH 0.74
- Revenue
- SBFM $34,874,283.00
- LTH $2,620,995,000.00
- Revenue This Year
- SBFM $192.48
- LTH $14.12
- Revenue Next Year
- SBFM N/A
- LTH $11.10
- P/E Ratio
- SBFM N/A
- LTH $42.11
- Revenue Growth
- SBFM 44.75
- LTH 18.24
- 52 Week Low
- SBFM $1.17
- LTH $12.34
- 52 Week High
- SBFM $33.60
- LTH $33.64
- Technical
- Relative Strength Index (RSI)
- SBFM 40.53
- LTH 53.85
- Support Level
- SBFM $1.17
- LTH $30.41
- Resistance Level
- SBFM $1.59
- LTH $31.67
- Average True Range (ATR)
- SBFM 0.17
- LTH 1.48
- MACD
- SBFM 0.04
- LTH 0.07
- Stochastic Oscillator
- SBFM 56.34
- LTH 79.53
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.